Russia has claimed that preliminary data shows its Sputnik V coronavirus vaccine is over 95% effective three weeks after the second dose. SEE: The Latest News on the Coronavirus Outbreak The country has priced the vaccine at under $10 a dose for international markets, which is s...
The market for these vaccines is the largest in pharmaceutical history." Sputnik-V is now reportedly being produced by India and South Korea while it will also start soon in China. Serbia and Italy would be the first countries in Europe to start their own localized producti...
Russia's Sputnik V coronavirus vaccine is 95-percent effective, according to a second interim analysis of clinical trial data, its developers said on Tuesday.The calculations were based on preliminary data obtained 42 days after the first dose, Russia's Health Ministry, Gamaleya Scientific Re...
Russian President Vladimit Putin will receive the SputnikV coronavirus vaccine, the Kremlin spokesman told state TV channel Rossiya 1, but no date has been set yet. "He said he will be vaccinated, he made this decision and was waiting until all formalities are completed," said Dmi...
Russia says it is in talks with multiple countries about supplying and making the Sputnik V vaccine. /Reuters/DADO RUVIC Meanwhile, Russia has reached an agreement with China to partner up in the production of more than 60 million doses of Sputnik V. ...
The Sputnik V vaccine is based on a proven and well-studied platform of human adenoviral vectors, which cause the common cold and have been around for thousands of years. Sputnik V uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer durat...
Russia was to export 250 million doses of the coronavirus (COVID-19) vaccine Sputnik V to India, which was among the major planned producers of the vaccine.
This criticism of the vaccine programme plays into a criticism of the country's political regime, thus showing the link between the reaction to Sputnik V and opinions on Putin’s rule. However, the website for the vaccine is accompanied by a Twitter account, with regular updates on deals ...
In Malaysia, Pharmaniaga Bhd is undertaking tail-end manufacturing for China’s Sinovac vaccine, namely fill-and-finish. Meanwhile, the vaccine procurement and distribution activities sanctioned by the Malaysian government, underlined three companies, namely Duopharma Biotech Bhd (Sputnik V), Solution Gro...
On Monday, Alexander Gintsburg, the director of Moscow’s Gamaleya Institute, which developed Sputnik V, the country’s first domestic Covid-19 vaccine for humans, warned animals could become a new frontline in the fight against the virus. He said that the pandemic“has not yet realized its...